HYPERTENSION: Primary & Secondary Mechanisms
Hypertension is a chronic elevation of arterial blood pressure that places sustained mechanical and biochemical stress on the cardiovascular system. Often called the “silent killer” because it may remain asymptomatic for years, hypertension gradually damages blood vessels, accelerates atherosclerosis and increases the workload of the heart.
Most cases are classified as primary (essential) hypertension, where no single cause can be identified but genetic, behavioural and environmental factors interact to raise blood pressure over time. Secondary hypertension arises from identifiable conditions such as renal disease, endocrine disorders or medication effects. Regardless of the cause, persistent elevation in pressure leads to predictable structural and functional changes throughout the body.
What You Need to Know
Blood pressure is determined by the interaction between cardiac output and systemic vascular resistance. Hypertension develops when one or both of these factors remain chronically elevated, most commonly due to increased resistance within the arterial system. In essential (primary) hypertension, no single cause is identified. Instead, small but persistent abnormalities in renal sodium handling, vascular smooth muscle tone, sympathetic nervous system activity, and hormonal regulation combine over time to raise baseline blood pressure. These changes lead to narrowing and stiffening of small arteries, reducing their ability to dilate and adapt to changes in flow demand.
As hypertension persists, the vasculature undergoes structural remodelling. Arterial walls thicken, lumens narrow, and elasticity is lost, particularly in resistance vessels. This increases systemic vascular resistance further, creating a self-perpetuating cycle where higher pressure promotes additional vascular change. The kidneys play a central role in this process. Impaired sodium excretion leads to volume expansion, while renal hypoperfusion stimulates activation of the renin–angiotensin–aldosterone system, reinforcing vasoconstriction and fluid retention.
The long-term impact of sustained hypertension is widespread and progressive:
Cardiac effects: increased afterload leads to left ventricular hypertrophy and, eventually, systolic or diastolic heart failure.
Renal effects: chronic glomerular injury from elevated intraglomerular pressure contributes to progressive kidney dysfunction.
Cerebrovascular and retinal effects: small vessel damage increases the risk of stroke, vascular dementia, and visual impairment.
Hypertension is therefore not simply a numerical abnormality on measurement, but a systemic disease that accelerates structural and functional damage across multiple organs. Early detection and sustained control are critical because vascular and end-organ changes often develop silently before clinical symptoms emerge.
Beyond the Basics
Mechanisms Underlying Primary (Essential) Hypertension
Primary hypertension develops from the cumulative effect of multiple interacting mechanisms rather than a single identifiable cause. A central contributor is altered renal sodium handling. When the kidneys retain sodium more readily, extracellular fluid volume expands, increasing venous return and cardiac output. Even small, sustained increases in volume can elevate arterial pressure over time, particularly when regulatory mechanisms fail to compensate appropriately.
Heightened sympathetic nervous system activity also plays a key role. Increased sympathetic tone promotes arteriolar vasoconstriction, raises heart rate, and stimulates renin release from the kidneys. This combination increases systemic vascular resistance while reinforcing sodium and water retention through downstream hormonal pathways. Environmental and metabolic factors such as chronic psychological stress, high dietary sodium intake, obesity, insulin resistance, and endothelial dysfunction further amplify these effects by impairing normal vasodilation and increasing baseline vascular tone.
As arterial pressure remains elevated, resistance vessels undergo structural adaptation. Vascular smooth muscle cells thicken and reorganise, narrowing the vessel lumen and reducing compliance. This remodelling increases arterial stiffness and systemic vascular resistance, meaning higher pressure is required to maintain flow. At this stage, hypertension becomes self-perpetuating, as the vascular changes induced by high pressure now act to sustain it.
Secondary Hypertension and Its Mechanisms
Secondary hypertension accounts for a smaller proportion of cases but is clinically significant because blood pressure may improve or normalise if the underlying cause is treated. Renal pathology is among the most important contributors. Chronic kidney disease reduces nephron number and impairs sodium excretion, while renal artery stenosis decreases renal perfusion pressure. In both settings, reduced renal blood flow activates the renin–angiotensin–aldosterone system, driving vasoconstriction and fluid retention.
Endocrine disorders raise blood pressure through excess hormone production that alters vascular tone or intravascular volume. Primary hyperaldosteronism increases sodium retention and potassium loss. Cushing’s syndrome exposes tissues to excess cortisol, enhancing vasoconstrictor sensitivity. Phaeochromocytoma produces episodic or sustained catecholamine excess, causing marked vasoconstriction and tachycardia. Thyroid dysfunction alters cardiac output and vascular responsiveness. Certain medications, including nonsteroidal anti-inflammatory drugs, corticosteroids, and oral contraceptives, can also elevate blood pressure by affecting renal perfusion, sodium balance, or vascular reactivity.
Cardiovascular Consequences: Increased Afterload and Ventricular Hypertrophy
Persistently elevated systemic vascular resistance increases left ventricular afterload, meaning the ventricle must generate higher pressure to eject blood into the aorta. In response, the myocardium undergoes concentric hypertrophy, with thickening of the ventricular wall aimed at reducing wall stress. Initially, this adaptation preserves systolic function and maintains cardiac output.
Over time, however, the hypertrophied myocardium becomes stiff and less compliant. Diastolic filling is impaired, leading to elevated left ventricular end-diastolic pressure and increased left atrial pressure. This pattern commonly progresses to heart failure with preserved ejection fraction, particularly in older adults and those with long-standing hypertension. The increased muscle mass also outstrips its blood supply, reducing coronary perfusion reserve and increasing susceptibility to myocardial ischaemia and arrhythmias.
Vascular and Microvascular Damage
Chronic hypertension exerts continuous mechanical stress on the vascular endothelium. Endothelial injury disrupts normal nitric oxide–mediated vasodilation and promotes inflammation, accelerating atherosclerotic plaque formation in large arteries. In smaller arteries and arterioles, sustained pressure leads to hyaline thickening or hyperplastic changes within the vessel wall, narrowing the lumen and compromising tissue perfusion.
In the kidneys, these microvascular changes damage glomerular capillaries, leading to sclerosis and progressive loss of filtration capacity. Cerebral vessels exposed to high pressure become vulnerable to rupture, resulting in haemorrhagic stroke, or to occlusion from atherosclerosis and small vessel disease, resulting in ischaemic stroke. Retinal vessels undergo similar changes, producing hypertensive retinopathy, which serves as a visible indicator of widespread microvascular injury.
Role of RAAS and Sympathetic Activation in Disease Progression
The renin–angiotensin–aldosterone system is a major driver of both blood pressure elevation and vascular remodelling. Angiotensin II causes potent vasoconstriction, stimulates aldosterone secretion, and promotes sodium and water retention. Beyond its haemodynamic effects, angiotensin II also stimulates vascular smooth muscle growth and fibrosis, contributing directly to arterial stiffening.
Sympathetic nervous system activation amplifies these processes by increasing heart rate, peripheral vascular resistance, and renin release. The interaction between sympathetic drive and RAAS activity creates reinforcing feedback loops that maintain elevated blood pressure and accelerate structural changes in the heart and vasculature. As these mechanisms persist, hypertension becomes increasingly resistant to simple volume or lifestyle modification alone, reflecting its transition from a functional disturbance to a chronic structural disease.
Clinical Connections
Hypertension is a major risk factor for cardiovascular morbidity and mortality. It often presents silently, making routine screening essential. Over time, patients may develop headaches, exertional dyspnoea or signs of end-organ damage, but most remain symptom-free until complications arise.
Management focuses on reducing blood pressure through lifestyle changes and pharmacotherapy. ACE inhibitors, ARBs, calcium channel blockers, beta blockers and diuretics target different components of the pathological process. Nurses play a key role in monitoring blood pressure trends, educating patients about medication adherence, supporting sodium restriction and identifying warning signs of accelerated hypertension or end-organ damage.
Concept Check
How does altered renal sodium handling contribute to primary hypertension?
Why does chronic hypertension lead to left ventricular hypertrophy?
What vascular changes occur in small arteries as a result of prolonged high pressure?
How do RAAS and sympathetic activation interact to maintain elevated blood pressure?
Why is hypertension considered a major risk factor for stroke and chronic kidney disease?